1968
DOI: 10.1212/wnl.18.1_part_1.1
|View full text |Cite
|
Sign up to set email alerts
|

Subacute necrotizing encephalomyelopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1968
1968
2002
2002

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…(Pyruvate and lactate levels fluctuate in normal persons and may appear increased in samples collected from a struggling infant, so one must be cautious in interpreting increased levels.) Treatment with thiamine by Greenhouse and Schneck (1968) and Clayton et al (1967) failed to influence either the clinical course or the increased levels of pyruvate and lactate. Treatment with lipoic acid by Clayton et al (1967) andHommes et al (1968) has been associated with some clinical benefit although, in the latter case, lipoic acid therapy failed to correct completely the decreased rate of lactate utilization.…”
Section: Etiologic Mechanismsmentioning
confidence: 91%
“…(Pyruvate and lactate levels fluctuate in normal persons and may appear increased in samples collected from a struggling infant, so one must be cautious in interpreting increased levels.) Treatment with thiamine by Greenhouse and Schneck (1968) and Clayton et al (1967) failed to influence either the clinical course or the increased levels of pyruvate and lactate. Treatment with lipoic acid by Clayton et al (1967) andHommes et al (1968) has been associated with some clinical benefit although, in the latter case, lipoic acid therapy failed to correct completely the decreased rate of lactate utilization.…”
Section: Etiologic Mechanismsmentioning
confidence: 91%
“…However, it is unlikely that the degenerative processes in the brain-stem would have been arrested, even if one had the capability of biochemically correcting the reported B6 and amine abnormalities. Furthermore, it is conceivable that these multiple enzymatic blockades, as reported in this paper and other studies (Greenhouse and Schneck 1968;Namiki, 1965;and Worsley et al, 1965), are the results of non-specific action of a substance or substances elaborated by the disease, capable of creating a massive breakdown in decarboxylating mechanisms everywhere. The evidence presented in this report indicates that the inhibition in decarboxylating systems might be due to impairment in catalytic utilization of vitamin B6 derivatives.…”
Section: Resultsmentioning
confidence: 52%
“…Among the possible biochemical abnormalities, thiamine deficiency (Leigh, 1951;Richter, 1957;Feigin and Woolf, 1954); impairments in thiamine utilization (Greenhouse and Schneck, 1968); chronic lactic acidosis (Namiki, 1965); elevated pyruvate level (Worsley, Brookfield, Elwood, Noble, and Taylor, 1965); and the presence of endogenously produced 'toxin' (Crome, 1964) have been reported. In this paper subnormalities in the activity of the enzymes decarboxylating 5-hydroxytryptophan, glutamic acid, and taurine, as well as impairment in utilization ofvitamin B6 derivatives, are reported.…”
mentioning
confidence: 99%
“…Familial incidence of the disease has also been reported by Namiki (1965) and Richter (1957). More recently, Greenhouse and Schneck (1968), after studying one case for metabolic defects related to thiamine deficiency and reviewing the literature of reported cases where lactic acid and pyruvic acid were found elevated, concluded that at the present time evidence for thiamine deficiency or lack of thiamine utilization in carbohydrate metabolism cannot be implicated as a cause of the disease. The authors sugge3t the need for detailed examination of the carbohydrate pathways of metabolism in an extensive manner in the hope of possibly realizing the causative metabolic factor.…”
Section: Discussionmentioning
confidence: 55%